Detalhe da pesquisa
1.
In Vitro Activity of Ceftibuten-Avibactam against ß-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program.
Antimicrob Agents Chemother
; 67(1): e0134622, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602322
2.
In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates.
Antimicrob Agents Chemother
; 67(12): e0034623, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971240
3.
In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program.
Antimicrob Agents Chemother
; 67(1): e0128122, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541767
4.
Multicenter Clinical Performance Evaluation of Omadacycline Susceptibility Testing of Enterobacterales on VITEK 2 Systems.
J Clin Microbiol
; 61(6): e0017423, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162363
5.
In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
J Antimicrob Chemother
; 78(8): 2019-2027, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390312
6.
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020.
BMC Microbiol
; 23(1): 165, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312049
7.
In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
Antimicrob Agents Chemother
; 66(1): e0130421, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662183
8.
In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021.
Antimicrob Agents Chemother
; 66(9): e0078122, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005804
9.
In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019.
Antimicrob Agents Chemother
; 66(2): e0199021, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807757
10.
In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes.
Antimicrob Agents Chemother
; 66(2): e0216521, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930028
11.
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-ß-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection.
Antimicrob Agents Chemother
; 66(11): e0093422, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286518
12.
Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012-2018.
Ann Clin Microbiol Antimicrob
; 21(1): 13, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313912
13.
Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey.
J Antimicrob Chemother
; 76(7): 1724-1730, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760099
14.
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems.
Antimicrob Agents Chemother
; 64(12)2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928739
15.
In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988095
16.
In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China.
J Antimicrob Chemother
; 75(7): 1833-1839, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306049
17.
Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451507
18.
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158270
19.
In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084745
20.
Erratum for Karlowsky et al., "In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019".
Antimicrob Agents Chemother
; 67(6): e0042723, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154749